Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers

Occupational and Environmental Medicine

Volumn 53, Issue 11, 1996, Pages 773-781

  Schnatter, A Robert ^a   Armstrong, Thomas W ^a   Nicolich, Mark J ^a   Thompson, Florence S ^b   Katz, Arnold M ^b   Huebner, Wendy W ^a   Pearlman, Eileen D ^a  

^a EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^b Imperial Oil Ltd Resources Limited   (Canada)

Author keywords

Benzene; Hydrocarbon; Leukaemia; Lymphoma; Multiple myeloma

Indexed keywords

BENZENE; PETROLEUM;

ADULT; AGED; ARTICLE; CANADA; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; LEUKEMIA; MALE; MYELOMA; NONHODGKIN LYMPHOMA; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029824526     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.53.11.773     Document Type: Article

References (45)

1. International Agency for Research on Cancer. Benzene. Some industrial chemicals and dyestuffs. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol 29. Lyon, France: IARC, 1982.
2. Austin H, Deizell E, Cole P. Benzene and leukemia: a review of the literature and a risk assessment. Am J Epidemiol 1988;127:419-39.
3. Sween GMH, Meijers JMM. Risk assessment of leukaemia and occupational exposure to benzene. Br J Ind Med 1989;46:826-30.
4. Infante PF. Benzene and leukemia: the 0·1 ppm ACGIH proposed threshold limit value for benzene. Appl Occup Environ Hyg 1992;7:253-62.
5. Lamm SH, Walters AS, Wilson R, Byrd DM, Grunwald H. Consistencies and inconsistencies underlying the quantitative assessment of leukemia risk from benzene exposure. Environ Health Perspect 1989;89:283-8.
6. Crump K. Risk of benzene-induced leukemia: a sensitivity analysis of the pliofilm cohort with additional follow-up and new exposure estimates. J Taxicol Environ Health 1994;42:219-42.
7. Decoufle P, Blattner WA, Blair A. Mortality among chemical workers exposed to benzene and other agents. Environ Res 1983;30:16-20.
8. Rinsky RA, Alexander B, Smith MD, Hornung R, Filloon TG, Young RJ, et al. Benzene and leukemia: an epidemiological risk assessment. N Engl J Med 1987;316: 1044-50.
9. Goldstein BD. Clinical hematotoxicity of benzene. In: Mehlman MA, ed. Advances in modern environmental toxicology, volume XVI, benzene: occupational and environmental hazards - scientific update. Princeton, NJ: Princeton Scientific Publishing, 1989:55-65.
10. Aksoy M, Erdem S, DinCol G. Leukemia in shoe-workers exposed chronically to benzene. Blood 1974;44:837-41.
11. Aksoy M. Benzene as a leukemogenic and carcinogenic agent. Am J Ind Med 1985;8:9-20.
12. Aksoy M. Leukemogenic and carcinogenic effects of benzene. In: Mehlman MA, ed. Advances in modern environmental toxicology, volume XVI, benzene: environmental health hazards scientific update. Princeton, NJ: Princeton Scientific Publishing, 1989:87-98.
13. Vigliani EC. Leukemia associated with benzene exposure. Ann N Y Acad Sci 1976;271:143-51.
14. Infante PF, Wagoner JK, Rinsky RA, Young RJ. Leukaemia in benzene workers. Lancet 1977;ii:76-8.
15. Paxton MB, Chinchilli VM, Brett SM, Rodricks JV. Leukemia risk associated with benzene exposure in the pliofilm cohort: I. Mortality update and exposure distribution. Risk Anal 1994;14:147-54.
16. Brett SM, Rodricks JV, Chinchilli VM. Review and update of leukemia risk potentially associated with occupational exposure to benzene. Environ Health Perspect 1989;82: 267-81.
17. Paxton MB, Chinchilli VM, Brett SM, Rodricks JV. Leukemia risk associated with benzene exposure in the pliofilm cohort: II. Risk estimates. Risk Anal 1994;14: 155-7.
18. Wong O. An industry wide mortality study of chemical workers occupationally exposed to benzene. II. Dose response analyses. Br J Ind Med 1987;44:382-95.
19. Bond GG, McLaren EA, Baldwin CL, Cook RR. An update of mortality among chemical workers exposed to benzene. Br J Ind Med 1986;43:685-91.
20. Paci E, Buiatti E, Seniori Costantini AR, Miligi L, Quinn M, Kaldor J, et al. Leukemia and aplastic anaemia in a shoeworker cohort exposed to benzene. In: C Hogstedt, C Reuterwall, eds. Progress in occupational epidemiology. Amsterdam: Elsevier, BV Biomedical Division, 1988: 133-6.
21. Vigliani EC, Saita G. Benzene and leukemia. N Engl J Med 1964;271:872-6.
22. Rushton L. Further follow up of mortality in a United Kingdom oil distribution centre cohort. Br J Ind Med 1993;50:561-9.
23. Schnatter AR, Katz AM, Nicolich MJ, Thériault G. A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect 1993;101(suppl 6):85-99.
24. Wong O, Harris F, Smith TJ. Health effects of gasoline exposure. II. Mortality patterns of distribution workers in the United States. Environ Health Perspect 1993;101 (suppl 6):63-76.
25. Christie D, Robinson K, Gordon I, Bisby J. A prospective study in the Australian petroleum industry. I. Mortality. Br J Ind Med 1991;48:507-10.
26. Schnatter AR, Thériault G, Katz AM, Thompson FS, Donaleski D, Murray N. A retrospective mortality study within operating segments of a petroleum company. Am J Ind Med 1992;22:209-29.
27. Armstrong TW, Pearlman ED, Schnatter AR, Bowes SM, Murray N, Nicolich MJ. Retrospective benzene exposure assessment for petroleum marketing and distribution epidemiology. Am Ind Hyg Assoc J 1996;57:333-43.
28. Checkoway H, Pearce N, Hickey JLS, Dement JM. Latency analysis in occupational epidemiology. Arch Environ Health 1990;45:95-100.
29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
30. Breslow NE, Day NE. Statistical methods in cancer research, vol I - the analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980.
31. Statistics and epidemiology research corporation EGRET manual addendum, revision 2. Seattle, WA: SERC, 1991.
32. Mehta CR, Patel NR, Grey R. Computing an exact confidence interval for the common odds ratio in several 2×2 contingency tables. Journal of the American Statistical Association 1986;80:392, and 969-73.
33. Wartenberg D, Northridge M. Defining exposure in case control studies: a new approach. Am J Epidemiol 1991; 133:1058-71.
34. SAS Institute. SAS/STAT software: changes and enhancements, release 6·07. Cary, NC: SAS, 1992. (SAS technical report P-229.)
35. Kinlen LJ, Rogot E. Leukemia and smoking habits among United States veterans. BMJ 1988;297:657-9.
36. Mills PK, Nowell GR, Beeson WL, Fraser GE, Phillips RL. History of cigarette smoking and risk of leukemia and myeloma: results from the adventist health study. J Natl Cancer Inst 1990;82:1832-6.
37. Siegel M. Smoking and leukemia: evaluation of a causal hypothesis. Am J Epidemiol 1993;138:1-9.
38. Linet MS, McLaughlin JK, Hsing AW, Wacholder S, Co-Chien HT, Schuman LM, et al. Cigarette smoking and leukemia results from the Lutheran brotherhood cohort study. Cancer Causes Control 1991;2:413-7.
39. Linet MS, McLaughlin JK, Hsing AW, Wacholder S, CoChien HT, Schuman LM, et al. Is cigarette smoking a risk factor for non-Hodgkin's lymphoma or multiple myeloma? Results from the Lutheran brotherhood cohort study. Leuk Res 1992;16:621-4.
40. Brown LM, Everett GD, Gibson R, Burmeister LF, Schuman LM, Blair A. Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes Control 1992;3:49-55.
41. Franceschi S, Serraino D, Bidoli E, Talamini R, Tirelli U, Carbone A, et al. The epidemiology of non-Hodgkin's lymphoma in the north-east of Italy: a hospital-based case control study. Leuk Res 1989;13:465-72.
42. Persson B, Frederksson M, Olsen K, Boeryd B. Axelson O. Some occupational exposures as risk factors for malignant lymphomas. Cancer 1993;72:1773-8.
43. Heineman EF, Zahm SH, McLaughlin JK, Vaught JB, Hrubec Z. A prospective study of tobacco use and multiple myeloma: evidence against an association. Cancer Causes Control 1992;3:391-2.
44. Tajima K. The 4th nationwide study of adult T-cell leukemia lymphoma in Japan: estimates of risk of ATL and its geographic and clinical features. Int J Cancer 1990;45:237-43.
45. Bourguet CC, Grufferman S, Delzell E, DeLong ER, Cohen HJ. Multiple myeloma and family history of cancer. Cancer 1985;56:2133-9.